Global Methotrexate Tablets 麻豆原创 Research Report 2023

Publication ID:

PB509236049

Publication Date:

September 28, 2023

Pages:

107

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Methotrexate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Methotrexate Tablets market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Methotrexate Tablets market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Accord Healthcare
Cipla
Morningside Healthcare
Ebewe Pharma
Orion
Nihon Generic
Nippon Zoki Pharmaceutical
Daito Pharmaceutical
Nichi-Iko Pharmaceutical
Towa Pharmaceutical
Mitsubishi Tanabe Pharma
Ayumi Pharmaceutical
Sinomune Pharmaceutical
Maoxiang Pharmacy
INE
Zhengqing Pharmaceutical
Segment by Type
2mg
2.5mg
10mg
Others
Segment by Application
Cancers
Rheumatoid Arthritis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Methotrexate Tablets report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, 麻豆原创 Channel and Customer Analysis
Chapter 8: 麻豆原创 Opportunities and Challenges
Chapter 9: 麻豆原创 Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Methotrexate Tablets 麻豆原创 Overview
1.1 Product Overview and Scope of Methotrexate Tablets
1.2 Methotrexate Tablets Segment by Type
1.2.1 Global Methotrexate Tablets 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 2mg
1.2.3 2.5mg
1.2.4 10mg
1.2.5 Others
1.3 Methotrexate Tablets Segment by Application
1.3.1 Global Methotrexate Tablets 麻豆原创 Value by Application: (2023-2029)
1.3.2 Cancers
1.3.3 Rheumatoid Arthritis
1.3.4 Others
1.4 Global Methotrexate Tablets 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Methotrexate Tablets Revenue 2018-2029
1.4.2 Global Methotrexate Tablets Sales 2018-2029
1.4.3 Global Methotrexate Tablets 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Methotrexate Tablets 麻豆原创 Competition by Manufacturers
2.1 Global Methotrexate Tablets Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Methotrexate Tablets Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Methotrexate Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Methotrexate Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Methotrexate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methotrexate Tablets, Product Type & Application
2.7 Methotrexate Tablets 麻豆原创 Competitive Situation and Trends
2.7.1 Methotrexate Tablets 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Methotrexate Tablets Players 麻豆原创 Share by Revenue
2.7.3 Global Methotrexate Tablets 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Methotrexate Tablets Retrospective 麻豆原创 Scenario by Region
3.1 Global Methotrexate Tablets 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Methotrexate Tablets Global Methotrexate Tablets Sales by Region: 2018-2029
3.2.1 Global Methotrexate Tablets Sales by Region: 2018-2023
3.2.2 Global Methotrexate Tablets Sales by Region: 2024-2029
3.3 Global Methotrexate Tablets Global Methotrexate Tablets Revenue by Region: 2018-2029
3.3.1 Global Methotrexate Tablets Revenue by Region: 2018-2023
3.3.2 Global Methotrexate Tablets Revenue by Region: 2024-2029
3.4 North America Methotrexate Tablets 麻豆原创 Facts & Figures by Country
3.4.1 North America Methotrexate Tablets 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Methotrexate Tablets Sales by Country (2018-2029)
3.4.3 North America Methotrexate Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Methotrexate Tablets 麻豆原创 Facts & Figures by Country
3.5.1 Europe Methotrexate Tablets 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Methotrexate Tablets Sales by Country (2018-2029)
3.5.3 Europe Methotrexate Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methotrexate Tablets 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Methotrexate Tablets 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Methotrexate Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Methotrexate Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Methotrexate Tablets 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Methotrexate Tablets 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Methotrexate Tablets Sales by Country (2018-2029)
3.7.3 Latin America Methotrexate Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Methotrexate Tablets 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Methotrexate Tablets 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Methotrexate Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Methotrexate Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Methotrexate Tablets Sales by Type (2018-2029)
4.1.1 Global Methotrexate Tablets Sales by Type (2018-2023)
4.1.2 Global Methotrexate Tablets Sales by Type (2024-2029)
4.1.3 Global Methotrexate Tablets Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Methotrexate Tablets Revenue by Type (2018-2029)
4.2.1 Global Methotrexate Tablets Revenue by Type (2018-2023)
4.2.2 Global Methotrexate Tablets Revenue by Type (2024-2029)
4.2.3 Global Methotrexate Tablets Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Methotrexate Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Methotrexate Tablets Sales by Application (2018-2029)
5.1.1 Global Methotrexate Tablets Sales by Application (2018-2023)
5.1.2 Global Methotrexate Tablets Sales by Application (2024-2029)
5.1.3 Global Methotrexate Tablets Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Methotrexate Tablets Revenue by Application (2018-2029)
5.2.1 Global Methotrexate Tablets Revenue by Application (2018-2023)
5.2.2 Global Methotrexate Tablets Revenue by Application (2024-2029)
5.2.3 Global Methotrexate Tablets Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Methotrexate Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Accord Healthcare Methotrexate Tablets Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Cipla Methotrexate Tablets Product Portfolio
6.2.5 Cipla Recent Developments/Updates
6.3 Morningside Healthcare
6.3.1 Morningside Healthcare Corporation Information
6.3.2 Morningside Healthcare Description and Business Overview
6.3.3 Morningside Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Morningside Healthcare Methotrexate Tablets Product Portfolio
6.3.5 Morningside Healthcare Recent Developments/Updates
6.4 Ebewe Pharma
6.4.1 Ebewe Pharma Corporation Information
6.4.2 Ebewe Pharma Description and Business Overview
6.4.3 Ebewe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ebewe Pharma Methotrexate Tablets Product Portfolio
6.4.5 Ebewe Pharma Recent Developments/Updates
6.5 Orion
6.5.1 Orion Corporation Information
6.5.2 Orion Description and Business Overview
6.5.3 Orion Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Orion Methotrexate Tablets Product Portfolio
6.5.5 Orion Recent Developments/Updates
6.6 Nihon Generic
6.6.1 Nihon Generic Corporation Information
6.6.2 Nihon Generic Description and Business Overview
6.6.3 Nihon Generic Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nihon Generic Methotrexate Tablets Product Portfolio
6.6.5 Nihon Generic Recent Developments/Updates
6.7 Nippon Zoki Pharmaceutical
6.6.1 Nippon Zoki Pharmaceutical Corporation Information
6.6.2 Nippon Zoki Pharmaceutical Description and Business Overview
6.6.3 Nippon Zoki Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nippon Zoki Pharmaceutical Methotrexate Tablets Product Portfolio
6.7.5 Nippon Zoki Pharmaceutical Recent Developments/Updates
6.8 Daito Pharmaceutical
6.8.1 Daito Pharmaceutical Corporation Information
6.8.2 Daito Pharmaceutical Description and Business Overview
6.8.3 Daito Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Daito Pharmaceutical Methotrexate Tablets Product Portfolio
6.8.5 Daito Pharmaceutical Recent Developments/Updates
6.9 Nichi-Iko Pharmaceutical
6.9.1 Nichi-Iko Pharmaceutical Corporation Information
6.9.2 Nichi-Iko Pharmaceutical Description and Business Overview
6.9.3 Nichi-Iko Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Nichi-Iko Pharmaceutical Methotrexate Tablets Product Portfolio
6.9.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
6.10 Towa Pharmaceutical
6.10.1 Towa Pharmaceutical Corporation Information
6.10.2 Towa Pharmaceutical Description and Business Overview
6.10.3 Towa Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Towa Pharmaceutical Methotrexate Tablets Product Portfolio
6.10.5 Towa Pharmaceutical Recent Developments/Updates
6.11 Mitsubishi Tanabe Pharma
6.11.1 Mitsubishi Tanabe Pharma Corporation Information
6.11.2 Mitsubishi Tanabe Pharma Methotrexate Tablets Description and Business Overview
6.11.3 Mitsubishi Tanabe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mitsubishi Tanabe Pharma Methotrexate Tablets Product Portfolio
6.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.12 Ayumi Pharmaceutical
6.12.1 Ayumi Pharmaceutical Corporation Information
6.12.2 Ayumi Pharmaceutical Methotrexate Tablets Description and Business Overview
6.12.3 Ayumi Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ayumi Pharmaceutical Methotrexate Tablets Product Portfolio
6.12.5 Ayumi Pharmaceutical Recent Developments/Updates
6.13 Sinomune Pharmaceutical
6.13.1 Sinomune Pharmaceutical Corporation Information
6.13.2 Sinomune Pharmaceutical Methotrexate Tablets Description and Business Overview
6.13.3 Sinomune Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sinomune Pharmaceutical Methotrexate Tablets Product Portfolio
6.13.5 Sinomune Pharmaceutical Recent Developments/Updates
6.14 Maoxiang Pharmacy
6.14.1 Maoxiang Pharmacy Corporation Information
6.14.2 Maoxiang Pharmacy Methotrexate Tablets Description and Business Overview
6.14.3 Maoxiang Pharmacy Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Maoxiang Pharmacy Methotrexate Tablets Product Portfolio
6.14.5 Maoxiang Pharmacy Recent Developments/Updates
6.15 INE
6.15.1 INE Corporation Information
6.15.2 INE Methotrexate Tablets Description and Business Overview
6.15.3 INE Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 INE Methotrexate Tablets Product Portfolio
6.15.5 INE Recent Developments/Updates
6.16 Zhengqing Pharmaceutical
6.16.1 Zhengqing Pharmaceutical Corporation Information
6.16.2 Zhengqing Pharmaceutical Methotrexate Tablets Description and Business Overview
6.16.3 Zhengqing Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Zhengqing Pharmaceutical Methotrexate Tablets Product Portfolio
6.16.5 Zhengqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methotrexate Tablets Industry Chain Analysis
7.2 Methotrexate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methotrexate Tablets Production Mode & Process
7.4 Methotrexate Tablets Sales and 麻豆原创ing
7.4.1 Methotrexate Tablets Sales Channels
7.4.2 Methotrexate Tablets Distributors
7.5 Methotrexate Tablets Customers
8 Methotrexate Tablets 麻豆原创 Dynamics
8.1 Methotrexate Tablets Industry Trends
8.2 Methotrexate Tablets 麻豆原创 Drivers
8.3 Methotrexate Tablets 麻豆原创 Challenges
8.4 Methotrexate Tablets 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Accord Healthcare
Cipla
Morningside Healthcare
Ebewe Pharma
Orion
Nihon Generic
Nippon Zoki Pharmaceutical
Daito Pharmaceutical
Nichi-Iko Pharmaceutical
Towa Pharmaceutical
Mitsubishi Tanabe Pharma
Ayumi Pharmaceutical
Sinomune Pharmaceutical
Maoxiang Pharmacy
INE
Zhengqing Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.